1. Home
  2. STXS vs BDSX Comparison

STXS vs BDSX Comparison

Compare STXS & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.30

Market Cap

164.1M

Sector

Health Care

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

N/A

Current Price

$21.09

Market Cap

153.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STXS
BDSX
Founded
1990
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.1M
153.3M
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
STXS
BDSX
Price
$1.30
$21.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$4.00
$32.50
AVG Volume (30 Days)
1.2M
53.8K
Earning Date
05-12-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
16.67
N/A
EPS
N/A
N/A
Revenue
$29,346,617.00
$88,499,000.00
Revenue This Year
$28.22
$25.26
Revenue Next Year
$30.47
$19.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.08
52 Week Low
$1.24
$0.35
52 Week High
$3.59
$24.92

Technical Indicators

Market Signals
Indicator
STXS
BDSX
Relative Strength Index (RSI) 32.44 57.01
Support Level N/A $19.00
Resistance Level $1.97 $24.47
Average True Range (ATR) 0.12 1.60
MACD -0.01 -0.16
Stochastic Oscillator 10.16 57.20

Price Performance

Historical Comparison
STXS
BDSX

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: